We found that p53 had the lowest binding energy, kcal/mol, which indicated that p53 was a key protein for the anti-tumor effect of Juglone, and the foundation to explore the mechanism of Juglone to inhibit the value added of colorectal cancer cells. This evidence concerns the gene TP53 and neoplasm.